Altshuler Shaham LTD Catalent, Inc. Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $47,506 - $58,626	-468 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $13,912 - $17,068	162 Added 52.94%	468 $49,000
Q3 2020 Nov 10, 2020	BUY	$72.74 - $92.5 $4,218 - $5,365	58 Added 23.39%	306 $26,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $11,908 - $19,601	248 New	248 $18,000
Q4 2019 Feb 11, 2020	SELL	$47.06 - $56.64 $8,470 - $10,195	-180 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $8,541 - $10,449	180 New	180 $9,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.